Acetylation of CCAR2 Establishes a BET/BRD9 Acetyl Switch in Response to Combined Deacetylase and Bromodomain Inhibition.
暂无分享,去创建一个
G. Johnson | E. Ho | M. Bedford | E. Vilar | L. Beaver | Deqiang Sun | R. Dashwood | Yun Huang | A. Ulusan | Jia Li | Shan Wang | F. Ertem | P. Rajendran | Mutian Zhang | H. Leung | Nhung Nguyen | Ying-Shiuan Chen | Li Li | K. Chang | D. Lieberman | Mohaiza W. Dashwood
[1] G. Johnson,et al. Heterocyclic Analogs of Sulforaphane Trigger DNA Damage and Impede DNA Repair in Colon Cancer Cells: Interplay of HATs and HDACs , 2018, Molecular nutrition & food research.
[2] Ling-Zhi Wang,et al. Targetable BET proteins- and E2F1-dependent transcriptional program maintains the malignancy of glioblastoma , 2018, Proceedings of the National Academy of Sciences.
[3] Anette McLeod,et al. Validation of histone deacetylase 3 as a therapeutic target in castration‐resistant prostate cancer , 2018, The Prostate.
[4] B. Bernstein,et al. Dual Targeting of Oncogenic Activation and Inflammatory Signaling Increases Therapeutic Efficacy in Myeloproliferative Neoplasms. , 2018, Cancer cell.
[5] S. Kummerfeld,et al. Non-canonical reader modules of BAZ1A promote recovery from DNA damage , 2017, Nature Communications.
[6] J. Qin,et al. Acetylation on histone H3 lysine 9 mediates a switch from transcription initiation to elongation , 2017, The Journal of Biological Chemistry.
[7] R. Nusse,et al. Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities , 2017, Cell.
[8] Y. Tai,et al. HDAC3 regulates DNMT1 expression in multiple myeloma: therapeutic implications , 2017, Leukemia.
[9] David E. Williams,et al. A functional pseudogene, NMRAL2P, is regulated by Nrf2 and serves as a coactivator of NQO1 in sulforaphane‐treated colon cancer cells , 2017, Molecular nutrition & food research.
[10] L. Aravind,et al. A conserved NAD+ binding pocket that regulates protein-protein interactions during aging , 2017, Science.
[11] Ming-Ming Zhou,et al. BET N-terminal bromodomain inhibition selectively blocks Th17 cell differentiation and ameliorates colitis in mice , 2017, Proceedings of the National Academy of Sciences.
[12] M. Abdelrahim,et al. Oncogenic targets Mmp7, S100a9, Nppb and Aldh1a3 from transcriptome profiling of FAP and Pirc adenomas are downregulated in response to tumor suppression by Clotam , 2017, International journal of cancer.
[13] P. Filippakopoulos,et al. Functions of bromodomain-containing proteins and their roles in homeostasis and cancer , 2017, Nature Reviews Molecular Cell Biology.
[14] María Jesús Fernández-Ávila,et al. A genome-wide screening uncovers the role of CCAR2 as an antagonist of DNA end resection , 2016, Nature Communications.
[15] H. J. Kim,et al. Positive regulation of β-catenin–PROX1 signaling axis by DBC1 in colon cancer progression , 2016, Oncogene.
[16] A. Rashid,et al. Development of a murine colonoscopic polypectomy model (with videos). , 2016, Gastrointestinal endoscopy.
[17] M. Koegl,et al. Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition , 2016, Nature chemical biology.
[18] D. Arango,et al. Dual Targeting of Bromodomain and Extraterminal Domain Proteins, and WNT or MAPK Signaling, Inhibits c-MYC Expression and Proliferation of Colorectal Cancer Cells , 2016, Molecular Cancer Therapeutics.
[19] Simon J Elsässer,et al. Genetic code expansion in stable cell lines enables encoded chromatin modification , 2016, Nature Methods.
[20] Amanda J. Guise,et al. The Proteomic Profile of Deleted in Breast Cancer 1 (DBC1) Interactions Points to a Multifaceted Regulation of Gene Expression* , 2015, Molecular & Cellular Proteomics.
[21] A. Chinnaiyan,et al. aBETting therapeutic resistance by Wnt signaling , 2015, Cell Research.
[22] David E. Williams,et al. Nrf2 status affects tumor growth, HDAC3 gene promoter associations, and the response to sulforaphane in the colon , 2015, Clinical Epigenetics.
[23] Francisco J. Sánchez-Rivera,et al. Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma , 2015, Nature Medicine.
[24] L. Zannini,et al. CCAR2/DBC1 is required for Chk2-dependent KAP1 phosphorylation and repair of DNA damage , 2015, Oncotarget.
[25] S. Westerheide,et al. DBC1/CCAR2 and CCAR1 Are Largely Disordered Proteins that Have Evolved from One Common Ancestor , 2014, BioMed research international.
[26] Thomas Wieland,et al. Alignment-Annotator web server: rendering and annotating sequence alignments , 2014, Nucleic Acids Res..
[27] U. Landegren,et al. Protein biomarker validation via proximity ligation assays. , 2014, Biochimica et biophysica acta.
[28] Marco Biasini,et al. SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information , 2014, Nucleic Acids Res..
[29] Jiandong Chen,et al. hMOF Acetylation of DBC1/CCAR2 Prevents Binding and Inhibition of SirT1 , 2013, Molecular and Cellular Biology.
[30] David E. Williams,et al. HDAC turnover, CtIP acetylation and dysregulated DNA damage signaling in colon cancer cells treated with sulforaphane and related dietary isothiocyanates , 2013, Epigenetics.
[31] Hassan Ashktorab,et al. Epigenetic inactivation of endothelin‐2 and endothelin‐3 in colon cancer , 2013, International journal of cancer.
[32] James E. DiCarlo,et al. RNA-Guided Human Genome Engineering via Cas9 , 2013, Science.
[33] Le Cong,et al. Multiplex Genome Engineering Using CRISPR/Cas Systems , 2013, Science.
[34] David E. Williams,et al. A role for low-abundance miRNAs in colon cancer: the miR-206/Krüppel-like factor 4 (KLF4) axis , 2012, Clinical Epigenetics.
[35] C. Löhr,et al. NADPH oxidase overexpression in human colon cancers and rat colon tumors induced by 2‐amino‐1‐methyl‐6‐phenylimidazo[4,5‐b]pyridine (PhIP) , 2011, International journal of cancer.
[36] David E. Williams,et al. Histone deacetylase turnover and recovery in sulforaphane-treated colon cancer cells: competing actions of 14-3-3 and Pin1 in HDAC3/SMRT corepressor complex dissociation/reassembly , 2011, Molecular Cancer.
[37] E. Chini,et al. HDAC3 Is Negatively Regulated by the Nuclear Protein DBC1* , 2010, The Journal of Biological Chemistry.
[38] William B. Smith,et al. Selective inhibition of BET bromodomains , 2010, Nature.
[39] H. Fukuhara,et al. Identification of DBC1 as a transcriptional repressor for BRCA1 , 2010, British Journal of Cancer.
[40] G. Gores,et al. Deleted in breast cancer-1 regulates SIRT1 activity and contributes to high-fat diet-induced liver steatosis in mice. , 2010, The Journal of clinical investigation.
[41] Arthur J. Olson,et al. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..
[42] Junjie Chen,et al. DBC1 is a negative regulator of SIRT1 , 2008, Nature.
[43] K. Henrick,et al. Inference of macromolecular assemblies from crystalline state. , 2007, Journal of molecular biology.
[44] J. Amos-Landgraf,et al. A target-selected Apc-mutant rat kindred enhances the modeling of familial human colon cancer , 2007, Proceedings of the National Academy of Sciences.
[45] U. Landegren,et al. Direct observation of individual endogenous protein complexes in situ by proximity ligation , 2006, Nature Methods.
[46] Yi Zhang,et al. Tudor, MBT and chromo domains gauge the degree of lysine methylation , 2006, EMBO reports.
[47] P. Karplus,et al. A Novel Mechanism of Chemoprotection by Sulforaphane , 2004, Cancer Research.
[48] Jaime Prilusky,et al. Automated analysis of interatomic contacts in proteins , 1999, Bioinform..
[49] B. Bernstein,et al. Dual Targeting of Oncogenic Activation and Inflammatory Signaling Increases Therapeutic Efficacy in Myeloproliferative Neoplasms. , 2018, Cancer cell.
[50] Jason J Paxman,et al. Bioinformatics Tools and Resources for Analyzing Protein Structures. , 2017, Methods in molecular biology.
[51] M. Bedford,et al. Protein-domain microarrays. , 2004, Methods in molecular biology.
[52] W. House,et al. Detection of mycoplasma in cell cultures. , 1967, The Journal of pathology and bacteriology.